BARRY OCONNOR
Head Senior Director, Biopharma Business Development Amea Guardant Health
Seminars
Wednesday 12th November 2025
Next-Generation Insights: Integrating Genomics & Epigenomics in Oncology Clinical Trials
4:25 pm
- Epigenomics: The new frontier for biomarker discovery
- Expand patient eligibility through combining genomic and epigenomic alterations
- Methylation-enhanced liquid biopsy improves deletion calling
